| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |